MedTrace Logo

A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children

NCT00390663 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2006-10-20

No results posted yet for this study

Summary

To determine whether the selective application of a combined treatment regimen of silver nitrate cautery and 4 weeks of Naseptin cream is superior to naseptin treatment alone in the management of recurrent paediatric epistaxis.

Conditions

Interventions

PROCEDURE

Nasal Cautery

Sponsors & Collaborators

  • NHS Greater Glasgow Yorkhill Division

    lead OTHER

Principal Investigators

  • Haytham Kubba, MBBS(Hons) MPhil FRCS FRCSEd · Royal Hospital for Sick Children

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00390663 on ClinicalTrials.gov